Acknowledgements |
|
vii | |
An introduction to the Fundamentals of Biomedical Science series |
|
viii | |
|
|
xii | |
Introduction |
|
1 | (2) |
|
|
2 | (1) |
|
|
3 | (31) |
|
|
|
|
3 | (1) |
|
1.2 Degradation of cells and tissues |
|
|
4 | (1) |
|
1.3 Sample preparation and storage |
|
|
5 | (11) |
|
|
16 | (5) |
|
1.5 Assessment of sample quality |
|
|
21 | (8) |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
30 | (1) |
|
|
30 | (2) |
|
|
32 | (1) |
|
|
32 | (1) |
|
|
32 | (2) |
|
2 The Molecular Laboratory |
|
|
34 | (15) |
|
|
|
|
34 | (1) |
|
2.2 Optimal molecular laboratory design |
|
|
35 | (3) |
|
2.3 Laboratory accreditation and quality management systems |
|
|
38 | (2) |
|
2.4 Validation and verification |
|
|
40 | (1) |
|
|
41 | (4) |
|
2.6 External quality assessment |
|
|
45 | (1) |
|
|
46 | (1) |
|
|
47 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (28) |
|
|
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (8) |
|
|
58 | (6) |
|
3.5 In situ hybridization |
|
|
64 | (4) |
|
|
68 | (1) |
|
|
69 | (3) |
|
|
72 | (1) |
|
|
72 | (1) |
|
|
72 | (3) |
|
|
75 | (1) |
|
|
76 | (1) |
|
4 Homogenate Sample Analysis |
|
|
77 | (36) |
|
|
|
|
|
77 | (1) |
|
4.2 Nucleic acid analysis |
|
|
78 | (18) |
|
|
96 | (12) |
|
|
108 | (5) |
|
|
108 | (1) |
|
|
109 | (1) |
|
|
109 | (2) |
|
|
111 | (1) |
|
|
112 | (1) |
|
5 Sequencing Technologies |
|
|
113 | (23) |
|
|
|
|
113 | (1) |
|
5.2 First-generation sequencing |
|
|
114 | (5) |
|
5.3 Second- or next-generation sequencing |
|
|
119 | (8) |
|
5.4 Third-generation sequencing |
|
|
127 | (3) |
|
|
130 | (1) |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
131 | (3) |
|
|
134 | (1) |
|
|
135 | (1) |
|
6 Molecular Analysis and Interpreting Molecular Data |
|
|
136 | (33) |
|
|
|
|
136 | (1) |
|
6.2 Data analysis of homogenate preparations |
|
|
137 | (18) |
|
6.3 Analysis of intact sample preparations |
|
|
155 | (5) |
|
6.4 Image capture and analysis |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
162 | (1) |
|
|
162 | (1) |
|
|
162 | (4) |
|
|
166 | (1) |
|
|
166 | (3) |
|
7 Recent Technical Advances in Molecular Analysis |
|
|
169 | (37) |
|
|
|
|
169 | (1) |
|
|
170 | (14) |
|
|
184 | (16) |
|
|
200 | (1) |
|
|
200 | (1) |
|
|
201 | (4) |
|
|
205 | (1) |
|
8 Haemopoietic Diseases 1: Leukaemias |
|
|
206 | (41) |
|
|
|
8.1 An introduction to leukaemia classification |
|
|
206 | (4) |
|
8.2 Acute myeloid leukaemia |
|
|
210 | (12) |
|
8.3 Chronic myeloid leukaemia |
|
|
222 | (5) |
|
8.4 Acute lymphoblastic leukaemia |
|
|
227 | (4) |
|
8.5 Chronic lymphocytic leukaemia (and other chronic lymphoid leukaemias) |
|
|
231 | (9) |
|
|
240 | (3) |
|
|
243 | (1) |
|
|
244 | (1) |
|
|
245 | (1) |
|
|
246 | (1) |
|
9 Haemopoietic Diseases 2: Lymphoproliferative Disorders |
|
|
247 | (23) |
|
|
|
|
247 | (1) |
|
9.2 Classification of non-Hodgkin lymphomas |
|
|
248 | (2) |
|
9.3 Diagnostic haematopathology |
|
|
250 | (14) |
|
|
264 | (2) |
|
|
266 | (1) |
|
|
266 | (1) |
|
|
266 | (1) |
|
|
266 | (3) |
|
|
269 | (1) |
|
|
270 | (21) |
|
|
|
|
|
270 | (1) |
|
10.2 Histopathological classification |
|
|
271 | (4) |
|
|
275 | (1) |
|
10.4 Sentinel lymph node assessment |
|
|
276 | (1) |
|
|
277 | (3) |
|
10.6 Molecular classification |
|
|
280 | (3) |
|
10.7 Gene expression profiling of breast cancer |
|
|
283 | (2) |
|
|
285 | (2) |
|
|
287 | (1) |
|
|
287 | (1) |
|
|
287 | (2) |
|
|
289 | (1) |
|
|
290 | (1) |
|
11 Epithelial Tumours and Melanoma |
|
|
291 | (37) |
|
|
|
291 | (1) |
|
|
292 | (12) |
|
11.3 Gastric and gastro-oesophageal adenocarcinoma |
|
|
304 | (3) |
|
|
307 | (4) |
|
|
311 | (2) |
|
11.6 Immuno-checkpoints in epithelial tumours and melanoma |
|
|
313 | (3) |
|
|
316 | (3) |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
320 | (6) |
|
|
326 | (1) |
|
|
327 | (1) |
|
|
328 | (20) |
|
|
|
328 | (1) |
|
12.2 Mesenchymal tumours associated with chromosomal translocations |
|
|
329 | (11) |
|
12.3 Mesenchymal tumours associated with gene amplification |
|
|
340 | (3) |
|
12.4 Mesenchymal tumours associated with point mutations |
|
|
343 | (2) |
|
12.5 Sarcomas associated with complex genomic events |
|
|
345 | (1) |
|
|
345 | (1) |
|
|
345 | (1) |
|
|
346 | (1) |
|
|
347 | (1) |
|
13 Prenatal and Neonatal Testing |
|
|
348 | (43) |
|
Claire V. S. Brasted-Pike |
|
|
|
348 | (1) |
|
|
349 | (5) |
|
13.3 Non-invasive testing |
|
|
354 | (7) |
|
|
361 | (2) |
|
13.5 Applications for prenatal testing |
|
|
363 | (9) |
|
13.6 Applications for neonatal testing |
|
|
372 | (5) |
|
13.7 Ethical considerations |
|
|
377 | (3) |
|
|
380 | (1) |
|
|
381 | (1) |
|
|
382 | (1) |
|
|
382 | (8) |
|
|
390 | (1) |
|
|
390 | (1) |
Abbreviations |
|
391 | (4) |
Index |
|
395 | |